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0929-6441/ª 2014, Elsevier Taiwan LLBackground: High-intensity focused ultrasound (HIFU) is an emerging technique for noninvasive
ablative treatment. However, HIFU has rarely been performed for the treatment of soft-tissue
tumors. Thus, we aimed to assess the feasibility and safety of performing extracorporeal HIFU
for the treatment of soft-tissue tumor. The treatment response was assessed using functional
magnetic resonance imaging (MRI) techniques.
Materials and methods: In the rabbit VX2 intramuscular tumor model, HIFU was performed us-
ing an extracorporeal HIFU device (YDME FEP-BY02) by varying the electric power from 50 to
400 W, with the other parameters being fixed. The HIFU beam was insonated to one layer of
focal spots having a depth of 8 mm. The degree of ablation was evaluated by histological ex-
amination and functional MRI techniques including dynamic contrast-enhanced MRI (DCE-MRI)
and apparent diffusion coefficient (ADC) map. The presence of skin burn was also evaluated.
Results: Applying HIFU with an electric power of 200 W discretely produced the ablation zone
without skin burn as planned before treatment (maximal depth: 8e9 mm), which shows the
suitability of using HIFU (with 200 W electric power) for the treatment of soft-tissue tumors.ng authors declare no conflicts of interest.
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100 K.W. Kim et al.By contrast, HIFU with an electric power of 100 W produced an ill-marginated ablation zone
with internal residual tumor foci, and HIFU with 300e400 W produced ablation zones with a
maximum depth of 13e24 mm, which far exceeded the planned depth and caused skin burn.
Perfusion maps of DCE-MRI demonstrated the devascularized ablation zone more conspicuously
than conventional contrast-enhanced T1-weighted images, and ADC map demonstrated the
surrounding edema or granulation tissue better than conventional T2-weighted images.
Conclusion: Extracorporeal HIFU treatment for soft-tissue tumor may be a feasible approach
with adjustment of input energy level. For post-treatment assessment, functional MRI tech-
niques including DCE-MRI and ADC map may be useful and complementary to conventional MRI.
ª 2014, Elsevier Taiwan LLC and the Chinese Taipei Society of Ultrasound in Medicine.
Open access under CC BY-NC-ND license.Introduction
High-intensity focused ultrasound (HIFU) is an emerging
ultrasound technique for noninvasive ablative treatment
[1]. Despite the expanding use of HIFU for the treatment of
various tumors, only a few studies were conducted on the
application of HIFU for soft-tissue tumors or intramuscular
tumors [2,3]. Soft-tissue tumors develop in the connective
tissues other than the bone, such as the skeletal muscle,
fat, fibrous tissue, or neurovascular tissue. Although soft-
tissue tumors can occur anywhere in the body, they are
most frequent in the extremities. At present, the standard
treatment of soft-tissue tumors in the extremities consists
of limb-sparing surgery and adjuvant radiation and/or
chemotherapy. However, in case of small soft-tissue tu-
mors, HIFU may be used as an alternative treatment,
because therapeutic ultrasound energy can penetrate soft
tissue with a relatively good sonic window compared with
that of deep-seated organs such as the liver or pancreas.
Determination of optimal in situ acoustic energy is
crucial to achieve focused complete ablation as well as to
avoid complications such as unnecessary extensive ablation
of adjacent soft tissue or major skin burns, which might be
prevented by adjusting HIFU treatment parameters. Thus,
we aimed to assess the feasibility and safety of HIFU
treatment using an extracorporeal HIFU device (YDME FEP-
BY02; Yuande Biomedical Engineering, Beijing, China) for
the treatment of soft-tissue tumor in a preclinical rabbit
model. Because ultrasound monitoring has limitations for
accurate assessment of treatment response after ablation
[4], multiparametric magnetic resonance imaging (MRI)
including dynamic contrast-enhanced MRI (DCE-MRI) and its
perfusion maps, diffusion-weighted images (DWIs), and an
apparent diffusion coefficient (ADC) map were evaluated
for treatment monitoring after HIFU.Materials and methods
Animal model
The intramuscular VX2 tumor model in rabbits was used in
this study. The VX2 tumor is a papilloma virus-induced
tumor of epithelial origin and permits allogenic trans-
plantation [5]. Ten adult New Zealand white rabbits, each
weighing 3.0e3.5 kg, were used in this study. The VX2tumor strain was maintained by successive transplantations
of tumor cells into the hind limbs of the carrier rabbits.
Anesthesia was induced by administering an intravenous
injection of ketamine hydrochloride (50 mg/kg body
weight; Ketamine, Yuhan, Korea) and 2% xylazine (0.1 mL/
kg; Rompun, Bayer, Germany). After shaving the para-
vertebral area, 0.15 mL of minced tumor was implanted
using an 18-gauge MEDICUT needle in the paravertebral
muscles symmetrically at both sides. An animal model
containing a superficially located intramuscular tumor was
prepared to evaluate both treatment efficacy and safety
(i.e., skin burn) of the HIFU treatment. Thus, we used ul-
trasonography for guiding the MEDICUT needle 1 cm below
the skin surface. This method allowed the growth of a
single, solitary, well-demarcated tumor in the superficial
layer of the paravertebral muscles of each recipient rabbit.
Two weeks following the tumor implantation and approxi-
mately when the tumors were expected to be round in
shape with a 1.5e2.0 cm diameter, HIFU was performed.
Among the 10 rabbits, one showed no tumor. Therefore, the
remaining nine rabbits underwent HIFU. The maximum
diameter of all 16 tumors, as seen on axial contrast MR
images, ranged from 1.4 to 2.2 cm (mean: 1.6  0.5 cm).
HIFU treatment
The FEP-BY02 HIFU system (Yuande Biomedical Engineering
Limited Corporation, Beijing, China) was used in our ex-
periments. The therapeutic HIFU transducer was a fixed
focus concave transducer, which contained 251 piezoelec-
tric elements with an overall aperture of 37 cm and a focal
length of 26 cm. The elements of the therapeutic trans-
ducer are driven in phase at a frequency of 1.04 MHz. The
focal zone of the therapeutic transducer was an elongated
ellipsoid with an axial length of 8 mm (6 dB) and radial
diameter of 3 mm. The diagnostic ultrasound system (GE
LOGIQ 5; GE Healthcare, Seongnam, Korea) with a 5-MHz
linear probe was mounted coaxially to the HIFU therapeutic
transducer. The tumors were imaged with the diagnostic
imaging transducer and positioned in the center of the focal
zone of the therapeutic transducer. The treatment area
and number of spots were then determined. The HIFU beam
was insonated into the tumor and moved successively
through each spot.
To identify the degree of ablation according to the en-
ergy delivered by the HIFU source, the electric power
HIFU Ablation of Tumors 101delivered to the HIFU transducer was varied from 50 to
400 W, while fixing the other parameters. Other treatment
parameters that this HIFU system allows the operator to
specify were set as follows: pulse length, 150 ms; inter-
mission time between pulses, 150 ms; duty factor, 0.5;
number of pulses per spot, 70; interval spacing between
spots, 3 mm; and the distance between the skin surface and
the HIFU focus, 5 mm. In this study, we applied HIFU
treatment to only one layer of focal spots, which has a
depth of 8 mm, even though the tumor depth exceeded
8 mm. We divided the rabbits into five groups and per-
formed HIFU to each group with different energy levels.
The treatment parameters are summarized in Table 1.
Depending on the tumor size, treatment duration varied
from 16 to 18 minutes. The HIFU technique was applied to a
tumor on one side of the paravertebral muscles, while the
tumor on the other side of the paravertebral muscles was
used as the control.
Multiparametric MRI acquisition
To evaluate the HIFU treatment response, MR imaging
studies were performed on Day 1 and Day 5 post-HIFU
treatment. All MR examinations were performed on a 3-
Tesla MR system (TIM Trio; Siemens Medical Systems, Erlan-
gen, Germany) with a standard eight-channel knee coil.
First, unenhanced T2-weighted images (T2-WIs) were ob-
tained with the following parameters: repetition time/echo
time (TR/TE), 4100/87 ms; matrix size, 128 128; slice
thickness, 3 mm; and field of view (FOV), 130  130 mm.
Second, unenhanced T1-weighted images (T1-WIs) were ac-
quired at each of the two flip angles for T1mapping using the
following parameters: TR/TE, 4.4/1.1 ms; flip angles
(a) Z 2 and 15; matrix size, 128 128; slice thickness,
3 mm; number of slices, 20; and FOV, 140 mm. DCE-MRI using
the T1-weighted radial gradient echo sequence was then
performed with an intravenous bolus injection of 0.1 mmol/
kg of gadopentetate dimeglumine (MAGNEVIST; Bayer
Schering, Seoul, Korea). The parameters used were as fol-
lows: TR/TE, 3.5/1.5 ms; flip angle (a) Z 11; matrix size,
128 128; slice thickness, 3 mm; number of slices, 20; and
FOV, 140mm. In this study, a hybrid three-dimensional stack-
of-stars trajectory was used. The DCE-MRI was continuously
scanned 20 times during 240 seconds. We used K-space-
weighted image contrast (KWIC) reconstruction technique to
obtain high temporal resolution, while maintaining high
spatial resolution [6]. With KWIC technique, four time-Table 1 Treatment parameters and results of high-intensity fo
Groups Power (W) Acoustic intensity
(ISATA, W/cm2)
Acoustic
energy (J)
1 50 388 263
2 100 776 526
3 200 1552 1052
4 300 2328 1578
5 400 3104 2104
a Results of the first rabbit/second rabbit in each group.
b Not available because the tumor was not grown in this rabbit.
c Not available because the rabbit died 3 hours after ablation, beforesolved subframe images were reconstructed from one
scan, enabling a 3-second temporal resolution in our study
(240 seconds/20 scans  4 subframe images). Using the
subframe, DCE-MRI images, voxelwise perfusion maps of the
volume transfer coefficient (K-trans) were generated with a
postprocessing software program (Tissue 4D; Siemens AG,
Erlangen, Germany), which is based on the Toftsmodel [7,8].
The DWI used a spin-echo echo-planar imaging sequence
(TR/TEZ 3800/69ms)with diffusion gradients applied in the
x, y, and z axes (bZ 500mm/s2). The FOVwas 130 130mm
and the matrix size was 64  64. The ADC values were
measured for each of the three directions (x, y, and z) and
averaged for the calculation of the final ADC value.
Gross examination and histology
The presence of skin burns was evaluated immediately
after ablation. At 5 days after ablation, the rabbits were
killed and frozen in a refrigerator at 70 C. Two days later,
each frozen rabbit was cut in a transverse plane using a
power saw, and gross specimens were sliced transversely at
5-mm intervals to match the MR images. The tissue was
processed by standard histopathological techniques and
stained with hematoxylin and eosin (H&E).
Results
Therapeutic effects according to the HIFU energy
level
The depth of the ablation zone became larger as the energy
of the HIFU beam increased (Table 1). In Group 1, which
was treated with the lowest HIFU power (50 W), the tumor
was not ablated at all, shown as contrast-enhancing mass
on MRI. When treating the tumors with an electric power of
100 W (Group 2) and 200 W (Group 3), the maximal depth of
the ablation zone measured on MRI reached 8e9 mm, which
was similar to the depth of focal spots (8 mm) as planned
before treatment. When we applied high input electric
power (300 W in Group 4 and 400 W in Group 5), the depth
of the ablation zone far exceeded the planned depth along
the beam axis (13e15 mm in Group 4 and 24 mm in Group
5). The ablated zones of Groups 3e5 were discretely pro-
duced (Fig. 1), while those of the Group 2 were less clearly
marginated with some residual viable tumor foci in the
ablation zone in the H&E histological section (Fig. 2).cused ultrasound treatment.
Maximum depth of
ablation zone (mm)a
Skin burna Survivala
0/NAb  þ
8/8 / þ/þ
8/9 / þ/þ
13/15 þ/þ þ/Died (5 days)
24/NAc þ/þþ þ/Died (3 hours)
re undergoing magnetic resonance imaging.
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with low energy level (Groups 1e3) tolerated the HIFU
treatment without significant event and showed normal
activity during 5 days of follow up after the treatment
(Table 1). One rabbit in Group 4 lost weight from 2.9 to
2.6 kg and died at 5 days after ablation. One rabbit in Group
5 died 3 hours after the HIFU therapy, probably due to
major burn injuries and/or anesthesia. Post mortem MRI
and autopsy were not performed. Skin burn occurred only in
rabbits of Groups 4 and 5. These results support that the
energy level used in Group 3 (power 200 W, ISATA 1552 W/
cm2, and acoustic energy 1052 J/spot) can be recom-
mended for HIFU treatment of the superficially located
soft-tissue tumors.Fig. 1 Magnetic resonance imaging performed 5 days after high-
200 W. (A) On the T2-weighted image (T2-WI), the hypointense ban
residual tumor (arrow). The hyperintense area posterior to the hy
matoxylin and eosin (40) histological specimen, which correspond
the ablation zone with coagulative necrosis (asterisks) and the viabl
devascularized area without any contrast enhancement (CE) on c
colored defect area on the K-trans color map overlapped on T1
diffusion-weighted image (DWI) and (F) high apparent diffusion co
shows high SI on (E) DWI and low ADC value on (F) ADC map.Multiparametric MRI findings of the ablation zone
On the MRIs obtained on Day 1 and Day 5 after the treat-
ment, the ablation zones were shown as devascularized
areas without enhancement on contrast-enhanced T1-WI,
while the remnant tumors were shown as contrast-
enhancing lesions (Figs. 1 and 2). The K-trans perfusion
map of DCE-MRI also demonstrated the ablation zones as
devascularized areas with a very low K-trans value near
zero (Fig. 1). The devascularized areas were more clearly
depicted in the K-trans perfusion map than in conventional
contrast-enhanced T1-WI. The T2-WI was not helpful to
delineate the ablation zone. On T2-WI, the completely
devascularized ablation zones were shown as hypointenseintensity focused ultrasound ablation with an electric power of
d (arrowheads) of the ablation zone is clearly distinct from the
pointense band is also part of the ablation zone. (B) The he-
s to the small box in (A) also shows a clear distinction between
e residual tumor (triangles). (C) The ablation zone is shown as a
ontrast-enhanced T1-weighted image (T1-WI) and (D) a gray-
-WI. (E) The ablation zone shows low signal intensity (SI) on
efficient (ADC) value on ADC map, whereas the residual tumor
Fig. 2 Magnetic resonance imaging performed 1 day after high-intensity focused ultrasound ablation with an electric power of
100 W. (A) On the T2-weighted image (T2-WI), both the ablation zone (arrowheads) and residual tumor (arrow) show high signal
intensity. (B) The hematoxylin and eosin (40) histological section, which corresponds to the small box in (A) shows the indistinct
margin between the area of coagulative necrosis (asterisks) and the viable residual tumor portion (triangles). (C) The ablation zone
(arrowheads) is not clearly distinct from adjacent muscle tissue on contrast-enhanced (CE) T1-weighted image, whereas (D) it is
well demonstrated as a devascularized area on the K-trans gray map. (E) On diffusion-weighted image (DWI), the residual tumor
(arrow) is not distinct from the ablated zone (arrowheads) and adjacent edema (curved arrow) due to similar degree of hyper-
intensity. (F) However, apparent diffusion coefficient (ADC) map clearly shows the residual tumor due to its low ADC value, whereas
the adjacent edema has a high ADC value.
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manifested as ill-marginated hyperintense areas. Necrotic
areas within the ablation zone were sometimes manifested
as hyperintense areas. The border of remnant tumor and
the edematous area were hardly differentiated on T2-WI
and DWI due to their similar degree of high signal in-
tensity. However, the ADC map enabled us to differentiate
the remnant tumor from edema, as the tumor showed a low
ADC value, whereas the edema had a high ADC value
(Fig. 2). These MRI findings did not differ either in 1 day
post-treatment MRIs and in 5 days post-treatment MRIs.
The H&E histological finding was correlated with
contrast-enhanced MR findings. The areas of coagulation
necrosis on histological specimen corresponded to the
devascularized areas on MRI. In the ablated tumors withhigh energy level (Groups 3e5), the areas of coagulation
necrosis were clearly distinguished from adjacent muscles
or viable tumor portions on both histological specimen and
contrast-enhanced MRI (Fig. 1B), whereas the tumors
treated with low energy level (Group 2) showed indistinct
margins between the ablated zones and the residual tumor
portions in both MRI and histological specimen (Fig. 2).Discussion
In this preclinical study to evaluate the feasibility and
safety of HIFU using an extracorporeal system (YDME FEP-
BY02) for the treatment of soft-tissue tumor, the area of
the ablation zone was dependent on the energy delivered
104 K.W. Kim et al.by the HIFU source. The energy level for Group 3 (power,
200 W; ISATA, 1552 W/cm2; and acoustic energy, 1052 J/
spot) might be suitable for superficially located small soft-
tissue tumors. Practically, the input power to HIFU device
and the HIFU exposure time are the commonly used
adjustable parameters for operators to set the HIFU pro-
tocol [9]. The in situ acoustic energy (EA) was calculated
based on the input electrical power (PE), efficiency of the
transducer (εT), estimation of tissue attenuation (a), and
total time of HIFU exposure/spot calculated by multiplying
the pulse length (tp), duty factor (df ), and number of
pulses per site [np; Eq. (1)] [10]. To achieve the desired in
situ acoustic energy, the input electric power should be
adjusted with respect to the estimated tissue attenuation,
which was calculated based on the tumor depth and skin
thickness. Because our experimental setting was used for a
superficial intramuscular tumor model (distance from the
skin surface to the HIFU focus: 5 mm), the input electric
power should be increased for HIFU treatment of deeper
lying tumors.
EAZPE$εT$10
a
10 $½tP$df$nP ð1Þ
In terms of HIFU exposure method and time, short pulses
with a duty factor of 0.5 were used for the total exposure
time of 10.5 seconds/spot considering the protocols of pre-
vious studies, which used this HIFU device [10e12]. It is well-
known that different biological consequences result from
different modes of ultrasound energy delivery. Continuous
exposure to a HIFU beam causes rapid increase in tissue
temperature to high degrees in a short period (a few sec-
onds/spot) and results in thermal coagulation necrosis [9].
Short-pulsed HIFU exposure with low repetition rate (duty
factor: 0.05e0.15) delivers the energy over a much longer
time (few minutes/spot) and predominantly causes me-
chanical effects such as cavitation with mild hyperthermia.
Therefore, it can be used to enhance the effect of concom-
itant chemotherapeutic drug or the delivery of the drug [13].
Although the continuous exposure provides uniform thermal
ablation rapidly, thermal safety in surrounding tissues should
be considered. A dose accumulation effect during periods of
continuous exposure could lead to unwanted thermal lesions
in surrounding tissues, especially along the beam axis (below
and above the beam axis) [14]. The rationale for adopting
short pulses with a duty factor of 0.5 (150 ms on and 150 ms
off) in this study is that it can provide uniform thermal
ablation of the target area while reducing the unwanted
thermal effect to surrounding tissues by reducing the dose
accumulation effect due to the cooling time between pulses.
Treatment assessment after HIFU ablation with short-
term follow-up imaging is very important to guide the
further treatment plan, which includes: (1) assessment of
the ablation zone with differentiation of unablated residual
tumor or adjacent muscle tissue; (2) characterization of
reactive change in the ablated zone such as surrounding
edema or granulation tissue; and (3) detection of
treatment-associated complications such as hemorrhage or
unexpected injury of adjacent organs. At present, MRI is
the best modality for fulfilling these goals of treatment
assessment after ablation [4].
Currently, contrast-enhanced T1-WI is known to be the
most useful sequence in conventional MRI for theevaluation of ablated zone, which is shown as an unen-
hanced devascularized area and can be differentiated from
enhancing residual tumor portion [4]. However, differenti-
ation between the ablation zone and the adjacent non-
ablated muscle tissue is sometimes difficult even on
contrast-enhanced T1-WI, because normal muscle tissue
may be barely enhanced on contrast-enhanced T1-WI.
Perfusion map of the DCE-MRI may differentiate the abla-
tion zone from the adjacent muscle tissue better than
contrast-enhanced T1-WI, as shown in Fig. 2, because the
perfusion map is highly sensitive to detect the perfusion
change of the tissue. It coincides with a previous report
about the perfusion map of the HIFU ablation zone of rabbit
thigh muscle, which revealed that K-trans and Ve maps
demonstrated the regions of histological change not visible
on conventional MRI and were more accurately correlated
with the histology [15].
Differentiating the residual tumor from the surrounding
edema or granulation tissue on conventional MRI is
frequently difficult, because the degree of T2 hyper-
intensity and contrast enhancement on T1-WI is similar in
both granulation tissue and residual tumor. The ADC map is
known to be helpful for differentiating the residual tumor
from the surrounding edema or granulation tissue at the
margin of the ablated zone, because the ADC value of re-
sidual tumor is lower than that of edema and granulation
tissue, as shown in Figs. 1 and 2 [4]. Our results showed that
the perfusion map of DCE-MRI and ADC map may be useful
to evaluate the short-term response after HIFU treatment.
In conclusion, extracorporeal HIFU treatment for soft-
tissue tumors appears to be feasible with adjustment of
input energy level. For treatment assessment after HIFU
treatment, functional MRI techniques including DCE-MRI
and ADC map may be useful to provide additional infor-
mation, which can complement conventional MRI
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